GlassScriptPhysician profile
Terry L Baldwin
NPI 1346276284
$4,518.44
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,336 · 2020: $551 · 2021: $1,736 · 2022: $829 · 2024: $66.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $66.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $66.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,223.58 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $856.97 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $688.71 | 2019-2022 | |
| Janssen Biotech, INC. | $346.03 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $243.87 | 2019-2022 | |
| Ucb, INC. | $176.87 | 2019-2020 | |
| Allergan, INC. | $157.20 | 2019 | |
| Pfizer INC. | $139.17 | 2019-2020 | |
| Celgene Corporation | $112.90 | 2021-2022 | |
| Boston Scientific Corporation | $90.09 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $82.67 | 2020-2021 | |
| Medtronic USA, INC. | $71.94 | 2019 | |
| Janssen Pharmaceuticals, INC | $69.28 | 2019 | |
| Abiomed | $66.40 | 2024 | Impella |
| Organon LLC | $48.81 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $31.39 | 2019-2021 | |
| Amgen INC. | $25.56 | 2022 | |
| Ethicon US, LLC | $18.25 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $15.01 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.93 | 2022 | |
| Intercept Pharmaceuticals, INC. | $14.46 | 2022 | |
| Shionogi INC | $12.94 | 2020 | |
| Ferring Pharmaceuticals INC. | $11.41 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,677.81 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Baldwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.